Local Anesthetic Treatment of Oral Pain in Patients With Mucositis
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Oral mucositis is a damage to the mucosa of the oral cavity and pharynx. It is a serious and
painful adverse effect caused by the radio therapy and/or chemo therapy patients with head
and neck cancer receive. The pain caused by oral mucositis can be difficult to treat as the
current treatment with opioids is not sufficient and can cause adverse effects.
Our hypothesis is that treatment with a local anesthetic lozenge with bupivacaine can reduce
the oral pain caused by mucositis compared with the current standard treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Hvidovre University Hospital
Collaborator:
Moberg Pharma, Sweden
Treatments:
Acetaminophen Anesthetics Anesthetics, Local Bupivacaine Gabapentin Lidocaine Morphine Pharmaceutical Solutions